Literature DB >> 1690415

Prognostic significance of nucleolar organizing regions (NORs) in carcinomas of the sigmoid colon and rectum.

J Rüschoff1, A Bittinger, K Neumann, P Schmitz-Moormann.   

Abstract

The prognostic significance of silver-binding nucleolar organizing regions (AgNORs) has been evaluated in tissue sections of biopsies taken from 70 primary adenocarcinomas of the colon sigmoid (n = 25) and rectum (n = 45) prior to their curative resection. A significant correlation between five-year survival rate and the mean AgNOR number per tumour cell (p less than 0.001) and the mean size of silver stained dots (p less than 0.05) was found according to the univariate Kaplan-Meier survival analysis. There was no significant relationship between AgNOR content and grade of malignancy, pT categories or pN categories. Multivariate survival analysis of covariates (Cox regression model) revealed a set of five variables that significantly influenced the patients' outcome: pN categories, AgNOR content, pT categories, maximum grade of malignancy and number of inflammatory cells. From the clinical and pathological parameters studied, pN and pT categories as well as the mean AgNOR number were the most important variables predicting death from colorectal carcinoma. Since the analysis of AgNORs can be performed on routinely processed paraffin-embedded tissue, this method may be of potential use in pretherapeutic assessment of the biologic aggressiveness of the disease.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1690415     DOI: 10.1016/S0344-0338(11)81014-9

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  13 in total

1.  RNA polymerase III transcripts and the PTB protein are essential for the integrity of the perinucleolar compartment.

Authors:  Chen Wang; Joan C Politz; Thoru Pederson; Sui Huang
Journal:  Mol Biol Cell       Date:  2003-06       Impact factor: 4.138

2.  Expression of interphasic nucleolar organizer regions in normal, dysplastic and neoplastic colorectal mucosa.

Authors:  P L Mingazzini; L Scucchi; D Di Stefano; F Malchiodi Albedi; F Ciaralli; M Falchi; V Marinozzi
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

3.  Nucleolar organizer regions in carcinomas of the oropharynx and hypopharynx.

Authors:  D Esser; F Theissig; C Willgeroth
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

4.  Nucleolar organizer regions in glottic carcinomas: comparison of DNA cytofluorometry and clinicopathological analysis.

Authors:  Y Yamamoto; T Itoh; T Saka; A Sakakura; H Takahashi
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

5.  Argyrophilic nucleolar organizer region counts and proliferating cell nuclear antigen scores are two reliable indicators of survival in pharyngeal carcinoma.

Authors:  A Pich; L Chiusa; P Pisani; M Krengli; F Pia; R Navone
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

6.  Nucleolar organizer regions in adenoid cystic carcinoma of the salivary glands.

Authors:  Y Yamamoto; T Itoh; T Saka; H Takahashi
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

7.  Ag-NOR protein distribution correlates with patient survival in stage I endometrial adenocarcinoma.

Authors:  D Trerè; A Cancellieri; A Perrone; G Rocchetta; G Pelusi; V Eusebi; M Derenzini
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

8.  Cytophotometric DNA content and argyrophilic nucleolar organiser regions of oesophageal carcinoma.

Authors:  M Morita; H Kuwano; S Tsutsui; S Ohno; H Matsuda; K Sugimachi
Journal:  Br J Cancer       Date:  1993-03       Impact factor: 7.640

Review 9.  Nucleolar organiser regions in pathology.

Authors:  M J Egan; J Crocker
Journal:  Br J Cancer       Date:  1992-01       Impact factor: 7.640

10.  Nucleolar organiser regions (AgNORs) as predictors in transitional cell bladder cancer.

Authors:  P K Lipponen; M J Eskelinen; S Nordling
Journal:  Br J Cancer       Date:  1991-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.